معرفی
Michael Naidoo is a researcher affiliated with the Centre for Physical Activity and Life Sciences, focusing on interdisciplinary research at the intersection of genetics, oncology, and neurobiology. His work explores the molecular basis of Duchenne Muscular Dystrophy (DMD) and its unexpected connections to cancer, particularly in context-dependent tumor suppression and oncogenicity.
His research interests include:
- Duchenne Muscular Dystrophy and Dystrophin isoforms (e.g., Dp71)
- Gene expression dynamics in cancer
- IDH mutant low-grade glioma prognosis
- Neuropathophysiology and cell migration mechanisms
- Bulk RNA sequencing and survival trends in oncogenetics
Michael’s publications highlight the dual role of the DMD gene in both neurological and oncological contexts, with a focus on molecular biomarkers. His work has been widely cited, appearing in high-impact journals like FEBS Open Bio and Scientific Reports, and has attracted significant attention on social media and in news outlets.
He has presented his findings at academic conferences, including an oral presentation on dystrophin Dp71’s role in cell migration and cancer. His collaborations span institutions, with co-authorships on studies linking DMD to glioma prognosis and tumor biology.
